Greg Democko

Greg Democko is a Principal Scientist at Chimerix, Inc., where responsibilities include managing outsourced analytical testing and budgets, alongside leading analytical projects for oral suspension development. With extensive experience in the pharmaceutical industry, Greg previously held positions at GlaxoSmithKline, contributing as an Investigator for emerging market R&D and as a Team Lead/Investigator in Analytical Development, where Greg managed stability testing and led multiple drug product projects. Prior roles also include Research Scientist at Triangle Pharmaceuticals and positions at GlaxoWellcome and Burroughs Wellcome. Greg holds a Bachelor of Science degree in Chemistry from Youngstown State University.